Related Experiment Video
Updated: Aug 11, 2026

06:53
Selective Harvesting of Marginating-hepatic Leukocytes
Published on: July 21, 2016
Regulation of human lymphocyte function by a soluble extract from normal human liver
Journal of Immunology (Baltimore, Md. : 1950)
|October 1, 1978
Summary
A liver extract (LEx) inhibits human lymphocyte activation and DNA synthesis, offering potential therapeutic applications for liver diseases. This immunomodulatory molecule reversibly blocks key immune responses without affecting T cell function.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Human peripheral blood lymphocytes (PBL) play a crucial role in immune responses.
- Phytohemagglutinin (PHA) and allogeneic cells are common stimulators used to study lymphocyte activation.
- Understanding immunomodulatory factors is key to managing liver diseases.
Purpose of the Study:
- To investigate the effect of a normal human liver extract (LEx) on lymphocyte activation.
- To characterize the properties and potential role of LEx in immune regulation.
- To explore LEx's relevance in liver pathology.
Main Methods:
- Lymphocyte blastogenesis and DNA synthesis assays using PHA and allogeneic cells.
- T lymphocyte E rosette formation assays.
- Partial purification of LEx via ultracentrifugation, ammonium sulfate precipitation, and chromatography.
Main Results:
- LEx reversibly inhibited PHA-induced PBL activation and DNA synthesis at low concentrations (0.7-1.5 microgram/culture).
- LEx did not affect T lymphocyte E rosette formation even at high concentrations (>900 microgram/culture).
- Purified LEx is a heat-labile protein (m.w. ~65,000, pI ~4.08), distinct from known immunoregulatory molecules.
Conclusions:
- LEx possesses potent immunomodulatory properties, specifically inhibiting lymphocyte activation and DNA synthesis.
- LEx is a novel molecule potentially released from injured liver cells.
- LEx may play a role in modulating immune responses in inflammatory and neoplastic liver diseases.

